Design of the trial of Org 10172 in acute stroke treatment (TOAST)
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier BV in Controlled Clinical Trials
- Vol. 18 (4), 358-377
- https://doi.org/10.1016/s0197-2456(97)00012-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and SafetyChest, 1995
- Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.Stroke, 1994
- Physician Attitudes towards Acute Stroke – A Comparison of Primary Care Physicians in Iowa and The NetherlandsCerebrovascular Diseases, 1993
- How Twin Cities Neurologists Treat Ischemic StrokeArchives of Neurology, 1993
- Low-Molecular-Weight Heparins and Heparinoids and their Use in Acute or Progressing Ischemic StrokeClinical Neuropharmacology, 1990
- Use of antithrombotic drugs in the treatment of acute ischemic strokeNeurology, 1989
- Early clinical experience of a new heparinoid, ORG 10172, in prevention of deep venous thrombosisThrombosis Research, 1987
- Progression of stroke after arrival at hospital.Stroke, 1985